financetom
Business
financetom
/
Business
/
Canadian precious metals royalties company OR Royalties' Q3 revenue jumps 
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Canadian precious metals royalties company OR Royalties' Q3 revenue jumps 
Nov 5, 2025 3:14 PM

Overview

* OR Royalties Q3 revenue rises to $71.6 mln from $42.0 mln in Q3 2024

* Net earnings for Q3 increase to $82.8 mln, reflecting strong financial performance

* Company achieves debt-free status after repaying revolving credit facility

Outlook

* Company expects first gold production at Dalgaranga in early 2026

* OR Royalties ( OR ) anticipates updates from Orla Mining and Osisko Development by year-end

* Company sees Harmony Gold optimizing CSA mine operations

Result Drivers

* GOLD EQUIVALENT OUNCES - Increase in gold equivalent ounces to 20,326 from 18,408 in Q3 2024 contributed to revenue growth

* CASH FLOW STRENGTH - Strong cash flows from operations enabled full repayment of revolving credit facility, achieving debt-free status

* STRATEGIC PAYMENTS - Payments related to discovery milestones and gold stream advances support future growth

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 $42.27

Adjusted mln

Net

Income

Q3 Net $82.85

Income mln

Q3 $0.055

Dividend

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the specialty mining & metals peer group is "buy"

* Wall Street's median 12-month price target for OR Royalties Inc ( OR ) is C$55.00, about 20.9% above its November 4 closing price of C$43.50

* The stock recently traded at 37 times the next 12-month earnings vs. a P/E of 41 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
TeraWulf Q1 Loss Narrows, Revenue Increases
TeraWulf Q1 Loss Narrows, Revenue Increases
May 13, 2024
04:32 PM EDT, 05/13/2024 (MT Newswires) -- TeraWulf ( WULF ) reported a Q1 loss late Monday of $0.03 per diluted share, narrower than a loss of $0.16 a year earlier. Four analysts polled by Capital IQ expected earnings of $0.03 per share. Revenue for the quarter ended March 31 was $42.4 million, up from $11.5 million a year earlier....
Avnet Insider Sold Shares Worth $1,008,437, According to a Recent SEC Filing
Avnet Insider Sold Shares Worth $1,008,437, According to a Recent SEC Filing
May 13, 2024
04:27 PM EDT, 05/13/2024 (MT Newswires) -- Philip R Gallagher, Director, Chief Executive Officer, on May 10, 2024, sold 19,532 shares in Avnet (AVT) for $1,008,437. Following the Form 4 filing with the SEC, Gallagher has control over a total of 310,501 shares of the company, with 140,792 shares held directly and 169,709 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/8858/000112760224015088/xslF345X03/form4.xml ...
Vaxart Stock Climbs After Blockbuster Q1 Revenue
Vaxart Stock Climbs After Blockbuster Q1 Revenue
May 13, 2024
Vaxart, Inc. ( VXRT ) reported its first-quarter financial results after the bell Monday. Here's a look at the details.  The Details: Vaxart ( VXRT ) reported quarterly losses of 14 cents per share, inline with the analyst consensus estimate. Quarterly sales clocked in at $2.181 million, beating the analyst consensus estimate of $800,000 by 172.63% and representing a 223.11%...
American Healthcare REIT Q1 Normalized FFO Declines, Revenue Rises; 2024 Normalized FFO Guidance Reaffirmed
American Healthcare REIT Q1 Normalized FFO Declines, Revenue Rises; 2024 Normalized FFO Guidance Reaffirmed
May 13, 2024
04:33 PM EDT, 05/13/2024 (MT Newswires) -- American Healthcare REIT ( AHRT ) reported Q1 normalized funds from operations Monday of $0.30 per diluted share, down from $0.31 a year earlier. Four analysts polled by Capital IQ expected an adjusted FFO of $0.25. Revenue in the quarter ended March 31 rose to $499.5 million from $452.2 million a year earlier....
Copyright 2023-2026 - www.financetom.com All Rights Reserved